Growth Metrics

BioNTech SE (BNTX) Receivables - Net (2018 - 2025)

BioNTech SE's Receivables - Net history spans 8 years, with the latest figure at -$73.3 million for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 104.69% to -$73.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$73.3 million, a 104.69% decrease, with the full-year FY2025 number at -$71.2 million, down 104.55% from a year prior.
  • Receivables - Net hit -$73.3 million in Q4 2025 for BioNTech SE, down from -$50.9 million in the prior quarter.
  • Over the last five years, Receivables - Net for BNTX hit a ceiling of $14.2 billion in Q1 2022 and a floor of -$73.3 million in Q4 2025.
  • Historically, Receivables - Net has averaged $4.0 billion across 5 years, with a median of $777.3 million in 2023.
  • The widest YoY moves for Receivables - Net: up 26824.21% in 2024, down 801.24% in 2024.
  • Tracing BNTX's Receivables - Net over 5 years: stood at $14.2 billion in 2021, then tumbled by 48.53% to $7.3 billion in 2022, then crashed by 99.92% to $5.8 million in 2023, then soared by 26824.21% to $1.6 billion in 2024, then crashed by 104.69% to -$73.3 million in 2025.
  • Business Quant data shows Receivables - Net for BNTX at -$73.3 million in Q4 2025, -$50.9 million in Q3 2025, and $1.5 billion in Q2 2025.